Puma Biotechnology (PBYI) Short-term Investments (2013 - 2026)

Puma Biotechnology (PBYI) has 14 years of Short-term Investments data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Short-term Investments fell 93.06% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 93.06% YoY) and the FY2025 annual result came in at $2.1 million, down 93.41% from the prior year.
• Short-term Investments steadied at $2.1 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $40.9 million in Q3 2025 to a low of $2.1 million in Q2 2025.
• A 5-year average of $16.7 million and a median of $11.4 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments soared 812.42% — and 2025, when it plunged 93.41%.
• Tracing PBYI's Short-term Investments over 5 years: stood at $4.9 million in 2022, then jumped by 133.0% to $11.4 million in 2023, then soared by 179.6% to $31.7 million in 2024, then slumped by 93.41% to $2.1 million in 2025, then changed by 0.0% to $2.1 million in 2026.
• The last three Short-term Investments figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $40.9 million (Q3 2025), per Business Quant data.